Browse All
Displaying 2116 - 2120 of 2652
Author:Pirahanchi, Yasaman Chuck, Carlin Azevedo, Jessica Stretz, Christoph Torabi, Radmehr Bavarsad Shahripour, Reza LaBuzetta, Jamie Karanjia, Navaz Steinberg, Jeffrey Khalessi, Alexander Furie, Karen Mahta, Ali
Session Name:P9: Neurocritical Care: Subarachnoid Hemorrhage and ICH
Topic:Neurocritical Care
Program Number:P9.006
Author Institution:Brigham and Women's Hospital, San Diego, CA Brown, Providence, RI UCSD Health, San Diego, CA Brown, RI Rhode Island Hospital, Providence, RI University of California, San Diego (UCSD), San Diego, CA UC San Diego Health, La Jolla, CA University of California San Diego, San Diego, CA UCSD, CA RIH/Alpert Medical School of Brown Univ, Providence, RI Brown University, Providence, RI
Author:Gatchoff, Philion Kirkpatrick, Angelia Xu, Chao Vincent, Andrea Mathews, Eleanor Guthery, Leslie Donna-Ferreira, Fabiola Dale, George Prodan, Calin
Session Name:P9: Cerebrovascular Disease and Interventional Neurology: Management of Intracranial Bleeds and Neurosurgical Disorders
Topic:Cerebrovascular Disease and Interventional Neurology
Author Institution:University of Oklahoma Health Sciences Center, Oklahoma City, OK University of Oklahoma Health Sciences Center/Oklahoma City VA Medical Center, Oklahoma City, OK University of Oklahoma , Norman, OK University of Oklahoma Health Sciences Center, OK
Author:Agac, Busranur Bhagavatheeshwaran, Govind Okar, Serhat V. Mina, Yair Reich, Daniel Cortese, Irene
Session Name:P9: Infectious Disease: Opportunistic Infections 1
Topic:Infectious Disease
Author Institution:National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD
Author:Tobar, Mariann Perez, Paola Aradi, Stephen Duffy, Alexandra Furr-Stimming, Erin Moore, Henry Mendizabal, Adys
Session Name:P9: Movement Disorders: Care Models and Patient Perceptions in Movement Disorders 2
Topic:Movement Disorders
Author Institution:UCLA, Los Angeles, CA UCLA, CA University of South Florida, Tampa, FL UC Davis Health, Sacramento, CA University of Texas Health Science Center-Houston, Houston, TX University of Miami - Miller School of Medicine, Miami, FL
Author:Pardo, Gabriel Montalban, Xavier Cohen, Jeffrey Morrow, Sarah Li, Jun Carr, David Pearce, Gregory Solonets, Maria Abeyewickreme, Anil de Seze, Jérôme Nakahara, Jin Wiendl, Heinz Hauser, Stephen
Session Name:P9: Multiple Sclerosis: Clinical Trials 2
Topic:Multiple Sclerosis
Author Institution:Oklahoma Medical Research Foundation, Oklahoma City, OK, USA, Oklahoma City, OK Department of Neurology/Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron, Barcelona, Spain, Barcelona, Spain Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada, calgary, AB, Canada Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland IQVIA RDS GmbH, Frankfurt, Germany, Germany Novartis Pharmaceuticals UK Ltd, London, United Kingdom, London, United Kingdom University Hospital of Strasbourg, Strasbourg, France, Strasbourg, France Department of Neurology, Keio University School of Medicine, Tokyo, Japan, Shinjuku-ku, Japan Klinik für Neurologie und Neurophysiologie, Universitätsklinikum Freiburg, Freiburg, Germany, Freiburg im Breisgau, Germany UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, USA, San Francisco, CA
